Denosumab-Induced Hypocalcemia after Billroth II Gastric Bypass Surgery

Hypocalcemia is a known risk following bariatric surgery and can contribute to the development of osteoporosis. Osteoporosis is commonly treated with denosumab, though denosumab can exacerbate underlying abnormalities in calcium homeostasis. We present the case of a 59-year-old female with severe hy...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmucker, Abigail M., Green, Dina E., Montemuro, Philip M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396013/
https://www.ncbi.nlm.nih.gov/pubmed/32774945
http://dx.doi.org/10.1155/2020/8833723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7396013/
https://www.ncbi.nlm.nih.gov/pubmed/32774945
http://dx.doi.org/10.1155/2020/8833723

Ejemplares similares